Reversible posterior leukoencephalopathy syndrome associated with left ventricular assist device

L. R. Williams, R. K. Darragh, D. K. Sokol, M. Edwards-Brown, M. W. Turrentine

Research output: Contribution to journalArticle

8 Scopus citations

Abstract

Reversible posterior leukoencephalopathy syndrome (RPLES), previously known as posterior reversible encephalopathy syndrome (PRES), is characterized by the presence of bilateral lesions located within the posterior border zones of the cerebral hemisphere and cerebellum. This condition commonly presents with headache, nausea, vomiting, decreased vision and level of consciousness, and seizures. RPLES has been associated with hypertensive encephalopathy, eclampsia, renal failure, and immunosuppressive therapy following transplant. We report the development of RPLES in a boy following implantation of a left ventricular assist device (LVAD). To our knowledge, this is the first report of RPLES in association with the use of LVAD.

Original languageEnglish (US)
Pages (from-to)4513-4514
Number of pages2
JournalTransplantation proceedings
Volume37
Issue number10
DOIs
StatePublished - Dec 1 2005

ASJC Scopus subject areas

  • Surgery
  • Transplantation

Fingerprint Dive into the research topics of 'Reversible posterior leukoencephalopathy syndrome associated with left ventricular assist device'. Together they form a unique fingerprint.

  • Cite this